Mercy Hospital in Chicago developed an interventional program around its hybrid cath labs, fostering collaboration ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 20, 2012 — The American College of Cardiology (ACC), in collaboration with several other professional societies ...
November 20, 2012 — Ischemic heart disease affects nearly 10 million Americans, and remains the leading cause of death ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
November 19, 2012 — Stryker announced the global commercial launch of the new Trevo ProVue Retriever. The Trevo ProVue ...
November 16, 2012 – The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot ...
November 15, 2012 — The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver PTX ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
Results from the POSEIDON Trial were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2012. Data showed a ...
The PC Trial data presented at TCT 2012 looked at transcather PFO closure vs. medical therapy in preventing cryptogenic ...
November 9, 2012 — Svelte Medical Systems announced it received conditional approval from the U.S. Food and Drug ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 9, 2012 — A study found that the use of rosuvastatin prior to angioplasty did not influence the levels of ...
November 8, 2012 — A clinical trial indicates that using an investigational medical device to close a PFO, or “hole in ...
November 8, 2012 — A hydration regimen tailored to the patient’s fluid status was effective in reducing damage to ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
November 8, 2012 — A U.S. Food and Drug Administration (FDA) advisory committee is meeting Dec. 5 to discuss how to ...
November 8, 2012 — Boston Scientific Corp. is extending its reach into the renal denervation market by signing a ...
The results of the FAME II Trial were presented at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) meeting. The ...
November 20, 2012